EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

TRAIL and RIPK3 Do Not Predict Mortality and Acute Kidney Injury in Critically Ill Patients at Admission to the Intensive Care Unit—A Single-Center Cohort Study

Katarzyna Kakareko iD, Alicja Rydzewska-Rosolowska iD, Irena Glowinska, Elzbieta Regulska iD, Karolina Rygasiewicz, Ewa Koc-Zorawska, Tomasz Hryszko iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189090 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Katarzyna Kakareko und 6 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Nephrology, Hypertension and Internal Medicine with Dialysis Unit, Medical University of Bialystok, 15-089 Bialystok, Poland. Hauptthemen laut MEDLINE: Critical Illness, Receptor-Interacting Protein Serine-Threonine Kinases, Acute Kidney Injury, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, National Science Centre, Poland (MINIATURA 4), Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TNF-related apoptosis-inducing ligand (TRAIL), a protein involved in apoptosis, and receptor-interacting serine/threonine protein kinase-3 (RIPK3), implicated in necroptosis, are known to change during organ damage and have been studied as prognostic markers in sepsis; however, cell death mechanisms also play a role in other critical illnesses. This study aimed to assess the utility of TRAIL and RIPK3 in predicting mortality and acute kidney injury (AKI) among unselected intensive care unit (ICU) patients. We performed a single-center prospective cohort study including 142 consecutive ICU admissions, collecting blood samples for TRAIL and RIPK3 measurement within 24 h of admission. The primary endpoints were in-hospital mortality and incident AKI during the ICU stay, with additional analysis of mortality over a two-year follow-up. Neither TRAIL nor RIPK3 levels at admission were significantly associated with in-hospital mortality, long-term mortality, or AKI incidence. However, higher RIPK3 levels correlated with shorter time to AKI occurrence. These results suggest that despite earlier evidence supporting their prognostic value in sepsis, TRAIL and RIPK3 did not reliably predict outcomes in a heterogeneous ICU population, underscoring the complexity of critical illness and the need for multiparametric biomarker strategies to improve risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessReceptor-Interacting Protein Serine-Threonine KinasesAcute Kidney InjuryTNF-Related Apoptosis-Inducing LigandHumansMaleFemaleIntensive Care UnitsMiddle AgedAgedHospital MortalityBiomarkersPrognosisProspective StudiesCohort StudiesSepsis

Stichwörter der Autor:innen

ICU stratificationRIPK3TNF-related apoptosis-inducing ligandTRAILcritically illreceptor-interacting serine/threonine protein kinase-3

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesTNF-Related Apoptosis-Inducing LigandRIPK3 protein, humanBiomarkersTNFSF10 protein, human

Autor:innen und Institutionen

  • 2nd Department of Nephrology, Hypertension and Internal Medicine with Dialysis Unit, Medical University of Bialystok, 15-089 Bialystok, Poland.
  • Faculty of Pharmacy, University of Castilla-La Mancha, 02008 Albacete, Spain.
  • Faculty of Chemistry, University of Bialystok, 15-089 Bialystok, Poland.
  • Department of Anesthesiology and Intensive Care, Medical University of Bialystok, 15-089 Bialystok, Poland.

ORCID-Profile: Katarzyna Kakareko, Alicja Rydzewska-Rosolowska, Elzbieta Regulska, Tomasz Hryszko

Förderung

  • National Science Centre
  • National Science Centre, Poland (MINIATURA 4)
  • Medical University of Bialystok

Zitieren

APA

Kakareko, K., Rydzewska-Rosolowska, A., Glowinska, I., Regulska, E., Rygasiewicz, K., Koc-Zorawska, E., & Hryszko, T. (2025). TRAIL and RIPK3 Do Not Predict Mortality and Acute Kidney Injury in Critically Ill Patients at Admission to the Intensive Care Unit—A Single-Center Cohort Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189090

Vancouver

Kakareko K, Rydzewska-Rosolowska A, Glowinska I, Regulska E, Rygasiewicz K, Koc-Zorawska E, et al. TRAIL and RIPK3 Do Not Predict Mortality and Acute Kidney Injury in Critically Ill Patients at Admission to the Intensive Care Unit—A Single-Center Cohort Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189090

BibTeX
@article{Kakareko2025,
  author = {Kakareko, Katarzyna and Rydzewska-Rosolowska, Alicja and Glowinska, Irena and Regulska, Elzbieta and Rygasiewicz, Karolina and Koc-Zorawska, Ewa and Hryszko, Tomasz},
  title = {TRAIL and RIPK3 Do Not Predict Mortality and Acute Kidney Injury in Critically Ill Patients at Admission to the Intensive Care Unit—A Single-Center Cohort Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189090}
}
Kostenlos starten →